Sanofi India, Emcure Pharma announce exclusive distribution partnership
Written by: Planify
Published: 18 March 2024
Updated: 18 March 2024
1 min read
Sanofi India and Emcure Pharmaceuticals on Monday announced an exclusive distribution and promotion agreement for Sanofi’s cardiovascular products in India. Effective immediately, Emcure Pharmaceuticals will exclusively distribute and promote Sanofi India’s Cardiovascular brands including Cardace, Clexane, Targocid, Lasix, and Lasilactone.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
